Recruiting Breast Cancer Studies in Melbourne
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Phase I: Characterize safety and tolerability of ECI830 as a single agent and in combination with ribociclib and fulvestrant. Identify dose range for optimization/recommended dose for future studies. ...
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
This first-in-human study will be counducted to evaluate the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of YH32367 in Patients with HER2-Positive Locally Advanced or Metastati...
About Breast Cancer Clinical Trials in Melbourne
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Melbourne, FL. These studies are seeking a combined 417 participants. Research is being sponsored by Novartis Pharmaceuticals, Yuhan Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Melbourne — FAQ
Are there breast cancer clinical trials in Melbourne?
Yes, there are 2 breast cancer clinical trials currently recruiting in Melbourne, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Melbourne?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Melbourne research site will contact you about next steps.
Are clinical trials in Melbourne free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Melbourne studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Melbourne are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov